These new medications, like copyright and Semaglutide, represent a important class of drugs called GLP-1 receptor agonists. They work by increasing the body's own ability to release GLP-1, a hormone that helps regulate glucose check here levels and appetite. Originally, created for addressing type 2 diabetes mellitus, they have furthermore shown ef